Edition:
United Kingdom

Anixa Biosciences Inc (ANIX.OQ)

ANIX.OQ on NASDAQ Stock Exchange Capital Market

3.50USD
26 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.50
Open
$3.65
Day's High
$3.65
Day's Low
$3.41
Volume
8,113
Avg. Vol
10,131
52-wk High
$6.86
52-wk Low
$3.01

Latest Key Developments (Source: Significant Developments)

Itus Corp - Co Entered Into An At Market Issuance Sales Agreement With B. Riley FBR, Inc
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Itus Corp ::ITUS CORP - ‍ON MARCH 27, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC TO CREATE AN AT MARKET EQUITY PROGRAM​.ITUS CORP - CO MAY SELL UP TO 2.2 MILLION SHARES OF COMPANY'S COMMON STOCK FROM TIME TO TIME THROUGH AGENT, AS SALES AGENT - SEC FILING​.  Full Article

Itus Corp Forms Alliance With Serametrix Corp
Monday, 5 Mar 2018 

March 5 (Reuters) - Itus Corp ::ITUS CORPORATION FORMS ALLIANCE WITH SERAMETRIX CORPORATION.‍ITUS, SERAMETRIX SIGNED AGREEMENT TO BRING CCHEK, CANCER DIAGNOSTIC TECHNOLOGY TO SERAMETRIX'S EXPERTISE IN IMMUNE MONITORING ASSAYS​.  Full Article

Itus Corporation Terminates At-The-Market Offering
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Itus Corp ::ITUS CORPORATION TERMINATES AT-THE-MARKET OFFERING.‍TERMINATED ITS AT-THE-MARKET EQUITY PROGRAM WITH B. RILEY FBR INC​.  Full Article

Itus enters into 2-year collaboration agreement
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Itus Corp ::Itus Corp - ‍on Nov 17, co, through unit entered into a 2 -year collaboration agreement with H. Lee Moffitt Cancer Center And Research Institute​.Itus - ‍ deal to advance toward human clinical testing car-t technology licensed by unit from Wistar Institute aimed initially at treating ovarian cancer​.Itus Corp says unit of co to pay Moffitt $1.16 million over two years for its efforts in collaboration - SEC filing.Itus Corp - unit to work with researchers at Moffitt to complete studies necessary to submit an IND application for technology with U.S. FDA​.Itus Corp - ‍first payment from unit to Moffitt to be paid upon execution of agreement, and subsequent installments to be paid periodically thereafter​.  Full Article

ITUS Corp licenses CAR-T technology from Wistar Institute
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - ITUS Corp :ITUS Corporation licenses CAR-T technology from the Wistar Institute.Itus Corp - ‍executed exclusive worldwide license agreement with Wistar Institute for a Chimeric Antigen Receptor T-Cell (CAR-T) technology.ITUS Corp - has formed a subsidiary, Certainty Therapeutics Inc, to develop and commercialize innovative CAR-T technology​.  Full Article

ITUS Corp files for stock shelf offering of up to $24 mln
Monday, 16 Oct 2017 

Oct 16 (Reuters) - ITUS Corp :ITUS Corp - files for stock shelf offering of up to $24 million - SEC filing‍​.  Full Article

Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stock​
Friday, 29 Sep 2017 

Sept 29 (Reuters) - Itus Corp ::Entered at-the-market issuance sales agreement with FBR capital to create equity program to sell up to $3.7 million common stock​.  Full Article

Itus Corp and Wistar Institute renew collaborative research agreement
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Itus Corp :The Wistar Institute and Itus Corporation renew collaborative research agreement.Itus corp - ‍ Itus and Wistar Institute have renewed their collaboration for development of CCHEK, the company's early cancer detection technology​.  Full Article

Itus Corp appoints Dr. Amit kumar as new CEO
Friday, 7 Jul 2017 

July 7 (Reuters) - Itus Corp :Itus appoints Dr. Amit Kumar as new CEO and announces management changes.Itus Corp says Amit Kumar replaces Robert Berman, who has resigned as president, CEO and as a director.Itus Corp says in addition, Mike Catelani, Itus' CFO, has been promoted to chief operating officer.  Full Article